Sirpa Osman

668 citations
6 papers · 551 indexed · h-index 6
Topics
Peptidase Inhibition and Analysis (3 papers)Pancreatic and Hepatic Oncology Research (2 papers)Glycosylation and Glycoproteins Research (2 papers)
Partner nations
FinlandGermany

In The Last Decade

Sirpa Osman

6 papers receiving 522 citations

Peers

Sirpa Osman
Comparison fields: 5 of 72
  • Oncology 282
  • Cancer Research 204
  • Surgery 172
  • Molecular Biology 117
  • Hematology 100
Replace Heikki Valleala with:
Heikki Valleala Finland
Hyun-Jeong Ra United States
Manali Bendre United States
Matthew F. Leeman United Kingdom
J Kishi Japan
Richard R. Renkiewicz United States
T Leizer Australia
Yoichi Ohiro Japan
M Keysser Germany
S. Spence McCachren United States
Sirpa Osman relative to Heikki Valleala Finland Heikki Valleala's profile →
Citations per field
00.5×1.5×2.3×
Heikki Valleala · 1×
Citations per year

Countries citing papers authored by Sirpa Osman

Since Specialization
Citations

This map shows the geographic impact of Sirpa Osman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sirpa Osman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sirpa Osman more than expected).

Fields of papers citing papers by Sirpa Osman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sirpa Osman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sirpa Osman. The network helps show where Sirpa Osman may publish in the future.

Co-authorship network of co-authors of Sirpa Osman

This figure shows the co-authorship network connecting the top 25 collaborators of Sirpa Osman. A scholar is included among the top collaborators of Sirpa Osman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sirpa Osman. Sirpa Osman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 131
2 186
3 10
4 40
5 91
6
Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix.
93

About Sirpa Osman

Sirpa Osman is a scholar working on Oncology, Cancer Research and Genetics, having authored 6 papers that have together received 551 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (204 citations), Oncology (282 citations) and Hematology (100 citations). Sirpa Osman has collaborated with scholars based in Finland and Germany. Frequent co-authors include Ulf‐Håkan Stenman, Erkki Koivunen, Outi Itkonen, M Vuento, Ari Ristimäki, Vesa Perhoniemi, Olli Saksela, V Sainio, Reijo Haapiainen and Johan Hedström. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026